Recurrent Ewing Sarcoma/Peripheral Primitive
1 clinical trials · Condition
◉ Watch Recurrent Ewing Sarcoma/Peripheral Primitive
| Record | Firm | Date |
|---|---|---|
| Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00831844) | National Cancer Institute (NCI) | 2009-01-01 |
Track Recurrent Ewing Sarcoma/Peripheral Primitive automatically
Every clearance here is in the API, with alerts when new ones post.